DTL
TVTX icon

Dynamic Technology Lab’s Travere Therapeutics TVTX Stock Holding History

Dynamic Technology Lab’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15,221
Closed -$137K – 1436
2023
Q4 		$137K Buy
+15,221
New +$111K 0.01% 924
2023
Q3 		– Sell
-19,537
Closed -$300K – 1339
2023
Q2 		$300K Buy
19,537
+3,997
+26% +$72.7K 0.04% 709
2023
Q1 		$349K Buy
+15,540
New +$330K 0.03% 746
2022
Q3 		– Sell
-15,520
Closed -$376K – 1538
2022
Q2 		$376K Buy
15,520
+2,170
+16% +$54.6K 0.04% 690
2022
Q1 		$344K Buy
+13,350
New +$354K 0.04% 727
2021
Q3 		– Sell
-32,469
Closed -$474K – 1472
2021
Q2 		$474K Buy
+32,469
New +$640K 0.05% 614
2020
Q1 		– Sell
-12,421
Closed -$176K – 1383
2019
Q4 		$176K Buy
+12,421
New +$159K 0.03% 855
2018
Q2 		– Sell
-11,323
Closed -$253K – 1329
2018
Q1 		$253K Sell
11,323
-9,077
-44% -$216K 0.04% 782
2017
Q4 		$430K Buy
20,400
+11,879
+139% +$271K 0.08% 511
2017
Q3 		$212K Buy
+8,521
New +$188K 0.03% 892
2017
Q2 		– Sell
-11,855
Closed -$219K – 1325
2017
Q1 		$219K Buy
+11,855
New +$232K 0.05% 751
2016
Q4 		– Sell
-12,261
Closed -$275K – 1174
2016
Q3 		$275K Buy
+12,261
New +$233K 0.07% 563
2016
Q2 		– Sell
-30,417
Closed -$416K – 1165
2016
Q1 		$416K Buy
30,417
+13,444
+79% +$204K 0.11% 356
2015
Q4 		$327K Buy
+16,973
New +$339K 0.1% 436

Other funds holding TVTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Dynamic Technology Lab's TVTX Position: Q1 2024 in Review

Dynamic Technology Lab sold out of Travere Therapeutics (TVTX) in Q1 2024, closing a stake of 15,221 shares — an estimated $137K sold.

Dynamic Technology Lab first reported a position in TVTX in Q4 2015 and held it in 14 quarters. The position peaked at $474K in Q2 2021. 175 funds tracked by Wall St. Rank hold TVTX as of Q1 2024.

  • Dynamic Technology Lab reported no remaining Travere Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Dynamic Technology Lab sold 15,221 Travere Therapeutics shares in Q1 2024, an estimated $137K.
  • Dynamic Technology Lab first reported a position in Travere Therapeutics in Q4 2015 and held it in 14 quarters.
  • Dynamic Technology Lab's Travere Therapeutics position peaked at $474K in Q2 2021.
  • 175 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2024.

Based on Dynamic Technology Lab's 13F filing for Q1 2024, filed 14 May 2024.